Perrigo launches store brand adult nutritional line
DUBLIN — Perrigo on Wednesday announced that its Nutritionals segment is partnering with KanPak to manufacture store brand adult nutritional drinks comparable to Ensure products. KanPak is a supplier of beverages and desserts using aseptic processing technology.
In 2013 Golden State Foods, one of the largest diversified food processors and distributors in the United States, acquired a controlling interest in KanPak. Perrigo will supply retailers with six store brand versions of the six nutritional drinks currently sold in the Ensure line. The adult nutritional drink market represents $900 million in annual branded sales for the last 12 months, as measured by SymphonyIRI Group.
"Our nutritionals team already supplies leading retailers with a range of nutritionals, from infant formula to adult vitamins, so this is a logical extension for our business," stated Joseph Papa, Perrigo chairman, president and CEO. "We made a significant investment into this partnership to bring quality, affordable healthcare products to retailers and the adult consumers they serve across the United States."
Study: A1C test not a reliable predictor of heart disease
CHICAGO — In a study that included nearly 300,000 adults without a known history of diabetes or cardiovascular disease, adding information about glycated hemoglobin (HbA1c), a measure of longer-term blood sugar control, to conventional CVD risk factors like smoking and cholesterol was associated with little improvement in the prediction of CVD risk, according to a study in the March 26 issue of JAMA.
Because higher glucose levels have been associated with higher CVD incidence, it has been proposed that information on blood sugar control might improve doctors’ ability to predict who will develop CVD, according to background information in the article.
Among the primary findings of the researchers, adding information on levels of HbA1c to conventional CVD risk factors was associated with only slight improvement in risk discrimination (how well a statistical model can separate individuals who do and do not go on to develop CVD). In addition, they found that adding information on HbA1c did not improve the accuracy of probability predictors for patients with and without CVD.
GSK to consumers: Some bottles of Alli OTC weight loss medication have been tampered with
MOON TOWNSHIP, Pa. — GlaxoSmithKline on Wednesday began alerting consumers that some bottles of its Alli over-the-counter weight-loss medication have been tampered with. "Consumer safety is GSK’s primary concern," the company stated. "We have initiated an investigation and are working with the Food and Drug Administration."
The outer carton of any tampered product may look authentic, but there are several tell-tale signs that the product has been tampered with, GSK cautioned, including:
- The bottle may contain a range of tablets and capsules of various shapes and colors;
- The bottle may not have a label;
- The bottle’s tamper evident seal may not be intact, not be made of foil and/or not have the authentic Alli wording: "Sealed for your Protection."; and
- The lot numbers and expiration dates on the bottle do not match the lot number and expiration date on the outer carton.
To date, some bottles bearing the following lot numbers and expiration dates on the carton have been reported to GSK by consumers as containing product other than Alli:
- Carton Lot 14372, Expiration: 02/28/2016;
- Carton Lot 14395, Expiration: 02/28/2016;
- Carton Lot 14124, Expiration: 09/30/2015;
- Carton Lot 14267, Expiration: 01/31/2016; and
- Carton Lot 14442, Expiration: 04/30/2016.
Tampered products were reportedly purchased by consumers at retail stores in the following seven states: Alabama, Florida, Louisiana, Mississippi, New York North Carolina and Texas.
Authentic Alli is a turquoise blue capsule with a dark blue band. It is packaged in a labeled bottle that has an inner foil seal imprinted with the words: "Sealed for your Protection." The same Lot and Expiration Date codes should be printed on both the bottle label and the outer carton.
Consumers should not use the product if the authentic Alli features as described above are not present, or if they have any concerns, GSK cautioned. "If you have consumed any product which you think may not be Alli, you should contact your healthcare provider," GSK stated.
GSK is seeking cooperation from consumers in this investigation. "If you suspect you have purchased any inauthentic Alli product, please promptly contact our Consumer Relations line at 800-671-2554 and a representative will provide you with further instructions. All product and packaging materials, including pamphlets, seals, etc. should be retained pending further instructions."